Edesa Biotech, . vs ImCheck Therapeutics
Edesa Biotech, . vs ImCheck Therapeutics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Edesa Biotech, . is on 17/100 and ImCheck Therapeutics on 60/100.
Where each one leads
Edesa Biotech, .
Leads on none of the measures we hold for both companies.
ImCheck Therapeutics
- our overall score: 60/100 against 17/100
- headcount: 47 against 23
- LinkedIn following: 11,647 against 2,102
At a glance
| Measure | Edesa Biotech, . | ImCheck Therapeutics |
|---|---|---|
| What it is | Edesa Biotech is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases. | ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies. |
| Category | Biotech, MedTech, Drug Discovery, Clinical Trials | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Biotech |
| Founded | Not published | 2015 |
| Headquarters | Markham, Canada | Marseille, France |
| Status | Active | Active |
Size, funding and growth
| Measure | Edesa Biotech, . | ImCheck Therapeutics |
|---|---|---|
| Employees | 23 | 47 |
| Total funding | Not published | $164M |
| LinkedIn followers | 2,102 | 11,647 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Edesa Biotech, . | ImCheck Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 17/100 | 60/100 |
| Traction | 14/100 | 57/100 |
| Team | Not published | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 20/100 | 22/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Edesa Biotech, . | ImCheck Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| Frameworks | Not detected | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Analytics 4 |
Edesa Biotech, . vs ImCheck Therapeutics: common questions
Which is better, Edesa Biotech, . or ImCheck Therapeutics?
On our 0-100 score ImCheck Therapeutics rates higher (60/100 against 17/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Edesa Biotech, . and ImCheck Therapeutics compare on the numbers?
ImCheck Therapeutics leads on our overall score (60/100 against 17/100), headcount (47 against 23), LinkedIn following (11,647 against 2,102).
Read the full Edesa Biotech, . review and pricing or the ImCheck Therapeutics review and pricing. You can also browse other Edesa Biotech, . alternatives we track.